Enliven Therapeutics
ELVN
#3853
Rank
NZ$6.25 B
Marketcap
NZ$87.55
Share price
2.17%
Change (1 day)
170.43%
Change (1 year)

Earnings for Enliven Therapeutics (ELVN)

Earnings in 2025 (TTM): -NZ$0.21 Billion

According to Enliven Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -NZ$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enliven Therapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$0.22 Billion14.45%
2024 -NZ$0.19 Billion25.17%
2023 -NZ$0.15 Billion115.33%
2022 -NZ$68.17 Million